Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6173059rdf:typepubmed:Citationlld:pubmed
pubmed-article:6173059lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:6173059lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:6173059lifeskim:mentionsumls-concept:C2243049lld:lifeskim
pubmed-article:6173059lifeskim:mentionsumls-concept:C0596402lld:lifeskim
pubmed-article:6173059lifeskim:mentionsumls-concept:C0021747lld:lifeskim
pubmed-article:6173059lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:6173059lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:6173059lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:6173059lifeskim:mentionsumls-concept:C0205296lld:lifeskim
pubmed-article:6173059pubmed:issue1lld:pubmed
pubmed-article:6173059pubmed:dateCreated1982-4-22lld:pubmed
pubmed-article:6173059pubmed:abstractTextOvernight incubation of human peripheral blood mononuclear (PBMN) cells with leucocyte interferon (leucocyte IFN) resulted in a 2-5-fold increase in natural cytotoxicity (NC) against the erythroleukaemic cell line K562. Fibroblast IFN, purified to homogeneity by zinc-chelate chromatography, stimulated NC to the same extent, while partially purified immune IFN was about twice as active. Upon gel filtration of immune IFN, NC stimulating and antiviral activity co-eluted. Treatment of PBMN cells with ammonium chloride buffer (AmCl) abrogated NC nearly completely. Incubation of AmCl-treated cells with leucocyte IFN resulted in a partial regeneration of NC. Kinetic studies revealed that this regeneration required only short exposure to IFN followed by a longer incubation period. The data are interpreted as indicating that in the process of NC activation IFN mainly acts as a trigger for precursor cells to mature into cells with NC.lld:pubmed
pubmed-article:6173059pubmed:languageenglld:pubmed
pubmed-article:6173059pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6173059pubmed:citationSubsetIMlld:pubmed
pubmed-article:6173059pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6173059pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6173059pubmed:statusMEDLINElld:pubmed
pubmed-article:6173059pubmed:monthJanlld:pubmed
pubmed-article:6173059pubmed:issn0007-1048lld:pubmed
pubmed-article:6173059pubmed:authorpubmed-author:BilliauAAlld:pubmed
pubmed-article:6173059pubmed:authorpubmed-author:VermylenCClld:pubmed
pubmed-article:6173059pubmed:authorpubmed-author:ClaeysHHlld:pubmed
pubmed-article:6173059pubmed:authorpubmed-author:De LeyMMlld:pubmed
pubmed-article:6173059pubmed:authorpubmed-author:Van DammeJJlld:pubmed
pubmed-article:6173059pubmed:issnTypePrintlld:pubmed
pubmed-article:6173059pubmed:volume50lld:pubmed
pubmed-article:6173059pubmed:ownerNLMlld:pubmed
pubmed-article:6173059pubmed:authorsCompleteYlld:pubmed
pubmed-article:6173059pubmed:pagination85-94lld:pubmed
pubmed-article:6173059pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:6173059pubmed:meshHeadingpubmed-meshheading:6173059-...lld:pubmed
pubmed-article:6173059pubmed:meshHeadingpubmed-meshheading:6173059-...lld:pubmed
pubmed-article:6173059pubmed:meshHeadingpubmed-meshheading:6173059-...lld:pubmed
pubmed-article:6173059pubmed:meshHeadingpubmed-meshheading:6173059-...lld:pubmed
pubmed-article:6173059pubmed:meshHeadingpubmed-meshheading:6173059-...lld:pubmed
pubmed-article:6173059pubmed:meshHeadingpubmed-meshheading:6173059-...lld:pubmed
pubmed-article:6173059pubmed:meshHeadingpubmed-meshheading:6173059-...lld:pubmed
pubmed-article:6173059pubmed:meshHeadingpubmed-meshheading:6173059-...lld:pubmed
pubmed-article:6173059pubmed:year1982lld:pubmed
pubmed-article:6173059pubmed:articleTitleActivation of natural cytotoxicity of human peripheral blood mononuclear cells by interferon: a kinetic study and comparison of different interferon types.lld:pubmed
pubmed-article:6173059pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6173059pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:6173059pubmed:publicationTypeIn Vitrolld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6173059lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6173059lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6173059lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6173059lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6173059lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6173059lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6173059lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6173059lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6173059lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6173059lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6173059lld:pubmed